机译:每周小剂量全身性甲氨蝶呤治疗与Vogt–Koyanagi–Harada病相关的慢性非感染性葡萄膜炎
Department of Ophthalmology, Yamaguchi University Graduate School of Medicine, 1-1-1 Minami-Kogushi, Ube, Yamaguchi, 755-8505, Japan;
Department of Ophthalmology, Yamaguchi University Graduate School of Medicine, 1-1-1 Minami-Kogushi, Ube, Yamaguchi, 755-8505, Japan;
Department of Ophthalmology, Yamaguchi University Graduate School of Medicine, 1-1-1 Minami-Kogushi, Ube, Yamaguchi, 755-8505, Japan;
Department of Ophthalmology, Yamaguchi University Graduate School of Medicine, 1-1-1 Minami-Kogushi, Ube, Yamaguchi, 755-8505, Japan;
机译:每周小剂量全身氨甲蝶呤治疗与Vogt-Koyanagi-Harada病相关的慢性非感染性葡萄膜炎
机译:vogt-koyanagi-harada病如类毒性脉冲治疗治疗后的粪便治疗后:案例报告
机译:HLA-DRB1 * 04:05在两种案例中,由持续施用Nivolumab和Dabrafenib / Trametinib疗法治疗的先进黑色素瘤患者的vogt-koyanagi-harada疾病样葡萄膜炎
机译:。 Vogt-Koyanagi-harada型病:案例报告
机译:膳食类黄酮摄入量与慢性阻塞性肺疾病,全身性炎症和合并症负担之间的关系
机译:vogt-koyanagi-harada病如类毒性脉冲治疗治疗后的粪便治疗后:案例报告
机译:Mofophenolate Mofetil联合全身性皮质类固醇,可防止进展到与Vogt-Koyanagi-harada病相关的初始发作急性葡萄膜炎中的慢性复发性炎症和'日落辉光眼底的发育